Clinical Trial Update: Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on magnesium supplementation for patients with advanced non-small cell lung cancer, a Phase 2/Phase 3 study that is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Magnesium supplement (Magnesium)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Metastatic NSCLC - Non-Small Cell Lung Cancer | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING